1033 related articles for article (PubMed ID: 22421533)
1. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
Silvestroff L; Bartucci S; Pasquini J; Franco P
Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
Franco PG; Silvestroff L; Soto EF; Pasquini JM
Exp Neurol; 2008 Aug; 212(2):458-67. PubMed ID: 18572165
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
4. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
5. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
Paez PM; Cheli VT; Ghiani CA; Spreuer V; Handley VW; Campagnoni AT
Glia; 2012 Jul; 60(7):1078-93. PubMed ID: 22447683
[TBL] [Abstract][Full Text] [Related]
6. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
7. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
8. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.
Yang HJ; Wang H; Zhang Y; Xiao L; Clough RW; Browning R; Li XM; Xu H
Brain Res; 2009 May; 1270():121-30. PubMed ID: 19306847
[TBL] [Abstract][Full Text] [Related]
9. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
[TBL] [Abstract][Full Text] [Related]
10. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination.
Hoyos HC; Rinaldi M; Mendez-Huergo SP; Marder M; Rabinovich GA; Pasquini JM; Pasquini LA
Neurobiol Dis; 2014 Feb; 62():441-55. PubMed ID: 24184798
[TBL] [Abstract][Full Text] [Related]
12. Cuprizone-induced demyelination in CNP::GFP transgenic mice.
Silvestroff L; Bartucci S; Soto E; Gallo V; Pasquini J; Franco P
J Comp Neurol; 2010 Jun; 518(12):2261-83. PubMed ID: 20437527
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
Skripuletz T; Hackstette D; Bauer K; Gudi V; Pul R; Voss E; Berger K; Kipp M; Baumgärtner W; Stangel M
Brain; 2013 Jan; 136(Pt 1):147-67. PubMed ID: 23266461
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
Clarner T; Parabucki A; Beyer C; Kipp M
J Neuroendocrinol; 2011 Jul; 23(7):601-11. PubMed ID: 21507085
[TBL] [Abstract][Full Text] [Related]
15. Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin.
Adamo AM; Paez PM; Escobar Cabrera OE; Wolfson M; Franco PG; Pasquini JM; Soto EF
Exp Neurol; 2006 Apr; 198(2):519-29. PubMed ID: 16480980
[TBL] [Abstract][Full Text] [Related]
16. Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.
Llufriu-Dabén G; Carrete A; Chierto E; Mailleux J; Camand E; Simon A; Vanmierlo T; Rose C; Allinquant B; Hendriks JJA; Massaad C; Meffre D; Jafarian-Tehrani M
Neurobiol Dis; 2018 Jan; 109(Pt A):11-24. PubMed ID: 28923597
[TBL] [Abstract][Full Text] [Related]
17. Differential changes in axonal conduction following CNS demyelination in two mouse models.
Bando Y; Takakusaki K; Ito S; Terayama R; Kashiwayanagi M; Yoshida S
Eur J Neurosci; 2008 Nov; 28(9):1731-42. PubMed ID: 18973589
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Nunes AK; Rapôso C; de Oliveira WH; Thomé R; Verinaud L; Tovar-Moll F; Peixoto CA
Exp Neurol; 2016 Jan; 275 Pt 1():143-53. PubMed ID: 26515692
[TBL] [Abstract][Full Text] [Related]
19. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
20. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
Hussain R; Ghoumari AM; Bielecki B; Steibel J; Boehm N; Liere P; Macklin WB; Kumar N; Habert R; Mhaouty-Kodja S; Tronche F; Sitruk-Ware R; Schumacher M; Ghandour MS
Brain; 2013 Jan; 136(Pt 1):132-46. PubMed ID: 23365095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
